Table 8 Adverse events following addition of carboplatin/gemcitabine combination as second-line NACT in the “intervention” group
Adverse event | Grade 1 | Grade 2 | Grade 3 | Grade 4 |
|---|---|---|---|---|
Anemia | 10 (40) | – | 10 (40) | – |
ALT rise | 10 (40) | 7 (28) | 1 (4) | – |
AST rise | 8 (32) | 2 (8) | – | – |
ALP rise | 5 (20) | – | – | – |
Neutropenia (↓ANC) | 6 (24) | 7 (28) | 3 (12) | – |
Leukopenia | 13 (52) | 4 (16) | 2 (8) | – |
Thrombocytopenia | 10 (40) | 1 (4) | 1 (4) | – |
Oral mucositis | 1 (4) | – | – | – |